Elizabeth Mittendorf

29PUBLICATIONS
278CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer cell biologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 05, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

|May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

|Apr 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.

|Nov 04, 2025
Cell populations in human breast cancers are molecularly and biologically distinct with age.

Adrienne Parsons, Esther Sauras Colón, Meghana Manjunath

|Oct 21, 2025
Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor-Positive Breast Cancer.

Megan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho

|Jun 04, 2025
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial.

Elizabeth A Mittendorf, Zoe June Assaf, Nadia Harbeck

Pageof 5

Frequent Collaborators

13 joint publications

Sara M Tolaney

9 joint publications

Nancy U Lin

8 joint publications

Nabihah Tayob

4 joint publications

Qingchun Jin